Evidence map›Paper›PMID 27463018›Full record

ArticleOncotarget2016

Loss of ZFP36 expression in colorectal cancer correlates to wnt/ ß-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of ZEB1, SOX9 and MACC1.

Lucia Montorsi, Filippo Guizzetti, Claudia Alecci, Andrea Caporali, Andrea Martello, Claudio Giacinto Atene, Sandra Parenti, Silvia Pizzini, Paola Zanovello, Stefania Bortoluzzi and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. The Roles of Zinc Finger Proteins in Colorectal Cancer.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Lucia MontorsiDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Filippo GuizzettiDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Claudia AlecciDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Andrea CaporaliUniversity/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Andrea MartelloUniversity/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Claudio Giacinto AteneDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Sandra ParentiDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Silvia PizziniCentre for Integrative Biology (CIBIO), University of Trento, Povo (Trento), Italy.
Paola ZanovelloDepartment of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padova, Padova, Italy.
Stefania BortoluzziDepartment of Molecular Medicine, University of Padova, Padova, Italy.
Sergio FerrariDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Alexis GrandeDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Tommaso Zanocco-MaraniDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
University of Modena and Reggio Emilia · ITUniversity of Edinburgh · GBUniversity of Padua · ITUniversity of Trento · IT

Funding

British Heart Foundation FS/11/52/29018British Heart Foundation FS/14/7/30574
6 · The paper itself

Abstract

The mRNA-destabilizing protein ZFP36 has been previously described as a tumor suppressor whose expression is lost during colorectal cancer development. In order to evaluate its role in this disease, we restored ZFP36 expression in different cell contexts, showing that the presence of this protein impairs the epithelial-to-mesenchymal transition (EMT) and induces a higher susceptibility to anoikis. Consistently, we found that ZFP36 inhibits the expression of three key transcription factors involved in EMT: ZEB1, MACC1 and SOX9. Finally, we observed for the first time that its expression negatively correlates with the activity of Wnt/β-catenin pathway, which is constitutively activated in colorectal cancer. This evidence provides a clue on the mechanism leading to the loss of ZFP36 in CRC.

Indexed as

beta CateninCell Line, TumorColorectal NeoplasmsEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansSOX9 Transcription FactorTrans-ActivatorsTranscription FactorsTristetraprolinUp-RegulationWnt Signaling PathwayZinc Finger E-box-Binding Homeobox 1beta CateninMACC1 protein, humanSOX9 protein, humanSOX9 Transcription FactorTrans-ActivatorsTranscription FactorsTristetraprolinZEB1 protein, humanZFP36 protein, humanZinc Finger E-box-Binding Homeobox 1colon cancerepithelial mesenchymal transitiontristetraprolinZFP36β-catenin

Identifiers

PMID27463018
PMCPMC5312301
OpenAlexW2484204804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.